Aprogen Biologics Inc. (KRX:003060)
South Korea · Delayed Price · Currency is KRW 236.00
+1.00 (0.43%)
At close: Apr 8, 2026
Aprogen Biologics Market Cap
Aprogen Biologics has a market cap or net worth of 46.63 billion as of April 8, 2026. Its market cap has decreased by -68.62% in one year.
Market Cap
46.63B
Enterprise Value
293.60B
Revenue
73.23B
Ranking
n/a
PE Ratio
n/a
Stock Price
236.00
Market Cap Chart
Since January 5, 1996, Aprogen Biologics's market cap has increased from 3.18B to 46.63B, an increase of 1,366.00%. That is a compound annual growth rate of 9.27%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 7, 2026 | 46.43B | -54.72% |
| Dec 30, 2025 | 102.54B | -21.60% |
| Dec 30, 2024 | 130.79B | -31.41% |
| Dec 28, 2023 | 190.68B | -4.89% |
| Dec 29, 2022 | 200.48B | -44.42% |
| Dec 30, 2021 | 360.71B | -31.18% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Dongwha Pharm.Co.,Ltd | 161.32B |
| Ilsung Is | 154.01B |
| HANDOK | 134.07B |
| Jeil Pharma Holdings | 124.96B |
| Ildong Holdings | 110.44B |
| CKD Bio | 101.33B |
| Kukje Pharma | 96.52B |
| Enzychem Lifesciences | 76.86B |